Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Revenue

Avadel Pharmaceuticals had revenue of $77.47M in the quarter ending September 30, 2025, with 54.86% growth. This brings the company's revenue in the last twelve months to $248.52M, up 79.88% year-over-year. In the year 2024, Avadel Pharmaceuticals had annual revenue of $169.12M with 504.79% growth.

• Revenue (ttm): $248.52M
• Revenue Growth: +79.88%
• P/S Ratio: 8.29
• Revenue / Employee: $1,321,899
• Employees: 188
• Market Cap: 2.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	169.12M	141.15M	504.79%
Dec 31, 2023	27.96M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	22.33M	-36.88M	-62.28%
Dec 31, 2019	59.22M	-44.05M	-42.66%
Dec 31, 2018	103.27M	-69.98M	-40.39%
Dec 31, 2017	173.25M	23.00M	15.31%
Dec 31, 2016	150.25M	-22.76M	-13.16%
Dec 31, 2015	173.01M	158.03M	1,055.32%
Dec 31, 2014	14.98M	10.80M	258.34%
Dec 31, 2013	4.18M	-3.36M	-44.53%
Dec 31, 2012	7.53M	-25.07M	-76.89%
Dec 31, 2011	32.60M	-4.49M	-12.12%
Dec 31, 2010	37.09M	-5.02M	-11.93%
Dec 31, 2009	42.12M	3.50M	9.06%
Dec 31, 2008	38.62M	1.97M	5.36%
Dec 31, 2007	36.65M	13.63M	59.23%
Dec 31, 2006	23.02M	-578.00K	-2.45%
Dec 31, 2005	23.60M	-	-